New capsule for central neuropathic pain
Part of Brain & nervous system, Pain clinical trials.
This trial tests a new capsule (HSK16149) for people with moderate to severe central neuropathic pain (pain from a spinal cord injury, stroke, Parkinson's, or multiple sclerosis). It aims to see if the drug can safely reduce pain and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- Your pain must be from a central nervous system condition (like spinal cord injury, stroke, Parkinson's disease, or multiple sclerosis).
- The pain has lasted for 3 months or more, and is moderate to severe (average pain score of 40 or higher on a 0–100 scale).
- You cannot have other painful conditions that might confuse the results.
- You must have normal blood counts, liver and kidney function, and not be pregnant or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug (HSK16149) for people with long-term diabetic nerve pain that hasn't been helped enough by pregabalin. It aims to see if the new capsule can reduce pain more effectively.
This trial tests an experimental pill for people with spinal cord injury who have long-term nerve pain. It aims to see if the drug can reduce pain and be safe.
This study tests a new drug (HL-1186) for diabetic nerve pain. It aims to see if it reduces pain safely in people with type 1 or type 2 diabetes who have had nerve pain for at least 6 months.
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
This study tests a new medication called HSK55718 to help manage pain after orthopedic (bone and joint) surgery. Researchers want to see if it works better or as well as other pain treatments and is safe to use.
This study looks at what “response profiles” different people have after treatment with high-concentration capsaicin for nerve-related pain. It may help doctors predict who benefits from capsaicin by measuring changes in symptoms and nerve sensitivity.
Hear when a new Central Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.